177Lu-Dotatate és a nagy dózisú, hosszú hatású oktreotid összehasonlítása előrehaladott, grade 1-2, jól differenciált gastroenteropancreaticus neuroendokrin tumoros betegek kezelésében (XT-XTR008-3-01): nyílt, randomizált, III. fázisú vizsgálat

Xu J (1†), Chen J (2, 3†), Song S (3,4,5,6†), Song (L7†), Wang (R8†), Hao J (9), Du X (10), Cao D (11), Gao Y (12), Lan X (13), Yang A (14), Miao W (15), Xu H (16), Chen Y (17, 18, 19), Li L (20), Shi H (21, 22, 23) Yuan X (24), Ye F (25), Wang J (26), Xu N (27), Han X (28), Li X (29), Huang R (30), Zhang T (31, 32, 33), Li E (34), Wang R (35), Zhou Y (36), Chen H (37), Zhu X (38), Zhao J (39), Su X (40), Cui Y (41), Ren P (42), Wang P (43)
(1) Senior Department of Oncology, Chinese PLA General Hospital, Beijing
(2) Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai
(3) Department of Oncology, Shanghai Medical College, Fudan University, Shanghai
(4) Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai
(5) Center for Biomedical Imaging, Fudan University, Shanghai
(6) Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai
(7) Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou
(8) Department of Nuclear Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing
(9) Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan
(10) Department of Oncology, Mianyang Central Hospital, Mianyang
(11) Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital and Sichuan University, Chengdu
(12) Department of Nuclear Medicine, People’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital, Zhengzhou
(13) Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
(14) The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an
(15) Department of Nuclear Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou
(16) Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou
(17) Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou
(18) Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou
(19) Institute of Nuclear Medicine, Southwest Medical University, Luzhou
(20) Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou
(21) Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai
(22) Shanghai Institute of Medical Imaging, Shanghai
(23) Institute of Nuclear Medicine, Fudan University, Shanghai
(24) Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
(25) Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen
(26) Department of Nuclear Medicine, Xijing Hospital, Xi’an
(27) Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
(28) The First Affiliated Hospital of Zhengzhou University, Zhengzhou
(29) Department of Nuclear Medicine, Qilu Hospital of Shandong University, Jinan
(30) Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu
(31) Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
(32) Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
(33) Hubei Key Laboratory of Precision Radiation Oncology, Wuhan
(34) Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an
(35) Department of Medical Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou
(36) Zhongshan Hospital, Fudan University, Shanghai
(37) Department of Nuclear Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen
(38) Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
(39) Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou
(40) Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
(41) Department of Oncology, Henan Provincial People’s Hospital, Zhengzhou
(42) Affiliated Hospital of Southwest Medical University, Luzhou
(43) Beijing Sinotau Intl. Pharmaceutical Technology Co., Ltd., Beijing, China